Skip to content

A study in healthy women to evaluate the effect of Intimate Glow Glider on reducing dark pigmentation and improving freshness in the external intimate area.

An Open-Label, Single-Arm, Interventional Clinical Study to Evaluate the Efficacy and Safety of Intimate Glow Glider for Reduction of Intimate Area Pigmentation and Improvement in Freshness Over a Period of 28 Days - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109542
Enrollment
34
Registered
2026-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Intimate Glow Glider: Topical product applied to the external intimate area once or twice daily for 28 days
external use only Control Intervention1: Not Applicable: This is an open-label, single-arm interventional study

Sponsors

SKINOVATE LASER & COSMETIC SURGERY CENTRE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy female subjects aged 18 45 years Visible mild to moderate pigmentation in external intimate area Good general and gynecological health Willing to comply with study requirements Provide written informed consent

Exclusion criteria

Exclusion criteria: Pregnant or breastfeeding women Active infections, lesions, or dermatoses in intimate area History of hypersensitivity to cosmetic/intimate products Use of: Topical treatments in intimate area (within 2 weeks) Systemic medication affecting skin (within 4 weeks) Sexually transmitted infections (current or recent) Participation in another clinical/cosmetic study within 30 days Any condition that may interfere with evaluation

Design outcomes

Primary

MeasureTime frame
To assess the reduction in darkness (skin lightening/pigmentation) in the intimate area after 28 days of product useTimepoint: To assess the reduction in darkness (skin lightening/pigmentation) in the intimate area after 28 days of product use

Secondary

MeasureTime frame
To evaluate fresh feeling throughout the day To assess skin comfort and irritation To evaluate overall subject satisfaction Timepoint: 28 Days

Countries

India

Contacts

Public ContactDr Avinash Bajirao Jadhav

Punawale Multispecialty Hospital

dr.avinashjadhav2@gmail.com07378306651

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026